Cardinal Health, Inc. operates within the healthcare sector offering a range of pharmaceutical and medical products. Despite facing industry challenges, their broad service scope helps in maintaining a stable presence in the market. With growing demand for healthcare services, CAH stands in a potentially promising position.
The following table indicates Cardinal Health's fundamental scores across various financial metrics. Overall, the stock ranks at a C+ level.
| Category | Score | |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 1 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 1 |
Below is a comparison of the historical and current scores for Cardinal Health's essential metrics.
| Date | Overall Score | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-12-24 | 2 | 4 | 1 | 4 | 1 | 2 | 1 |
| Historical Data | 0 | 4 | 1 | 4 | 1 | 2 | 1 |
Analysts have set the following price targets for Cardinal Health, with a consensus rating of "Buy". The data is illustrated in the table below:
| High | Low | Median | Consensus |
|---|---|---|---|
| 243 | 186 | 220 | 215 |
Analysis of the analyst sentiment reveals a favorable outlook with predominant "Buy" recommendations:
| Recommendation | Count | |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 17 | |
| Hold | 16 | |
| Sell | 0 | |
| Strong Sell | 0 |
Cardinal Health, Inc. shows promising potential within an expanding healthcare industry. Though the stock's fundamental score is currently at a C+ level, strong "Buy" ratings from analysts indicate confidence in its future performance. Investors should consider the company’s comprehensive service offerings as a strength amidst economic challenges. Potential risks include operational costs and market competition in the healthcare sector. Overall, cautious optimism is advised.